Retinoic acid is a negative regulator of AP-1-responsive genes.

Roland Schüle(Howard Hughes Medical Institute), Pundi N. Rangarajan(Howard Hughes Medical Institute), Na Yang(Howard Hughes Medical Institute), Steven A. Kliewer(Howard Hughes Medical Institute), Lynn J. Ransone(Salk Institute for Biological Studies), Jack Bolado(Howard Hughes Medical Institute), Inder M. Verma(Howard Hughes Medical Institute), Ronald M. Evans(Howard Hughes Medical Institute)
Proceedings of the National Academy of Sciences
July 15, 1991
Cited by 540Open Access
Full Text

Abstract

We present evidence that retinoic acid can down-regulate transcriptional activation by the nuclear protooncogene c-jun. All three members of the retinoic acid receptor (RAR) subfamily (RAR alpha, RAR beta, and RAR gamma) can repress transcriptional induction of the human collagenase gene or a heterologous promoter that contains the collagenase promoter AP-1-binding site. In contrast, the retinoid X receptor fails to repress Jun/AP-1 activity, demonstrating a significant difference between the two regulatory systems through which retinoids exert their transcriptional control. Analysis of RAR alpha mutants in transfection studies reveals that the DNA-binding domain is important for the inhibition of Jun/AP-1 activity, even though the RAR does not bind the collagenase AP-1 site. Rather, gel-retardation assays reveal that bacterially expressed full-length RAR alpha inhibits binding of Jun protein to target DNA. These data suggest that the RAR alpha may form a nonproductive complex with c-Jun and provides a simple mechanisms by which retinoic acid may limit cell growth and possibly malignant progression.


Related Papers

No related papers found

Powered by citation graph analysis